Advocacy intelligence hub — real-time data for patient organizations
Hemab ApS — PHASE2
Equilibra Bioscience LLC — PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Massimo Iacobelli, MD
Consultant
guglielmo mariani, md
University of L'Aquila
Ingrid Pabinger-Fasching, Prof.
Universitätsklinik für Innere Medizin I der Stadt Wien
Mohammad Faranoush, MD
Hazrat Rasool Akram Hospital, MAHAK Children's Hospital, Iran University of Medical Sciences, Tehran
Alex Veldman
CSL Behring
Renchi Yang
Hematology Hospital, Chinese Academy of Medical Sciences